Last quarter (Q3 2024), VistaGen Therapeutics's total revenue was $411.40K, an increase of Infinity% from the same quarter last year. In Q3, VistaGen Therapeutics's net income was $-6.35M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	$ 689.10K	$ -227.00K	$ 1.11M	$ 1.09M	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 689.10K	$ -227.00K	$ 1.11M	$ 1.09M	-	-
Operating Expense	$ 22.35M	$ 59.04M	$ 48.89M	$ 19.02M	$ 19.97M	$ 24.53M
Operating Income	$ -21.66M	$ -59.27M	$ -47.78M	$ -19.02M	$ -19.97M	$ -24.53M
Net Non Operating Interest Income Expense	$ 1.82M	$ 26.20K	$ 19.90K	$ 1.60K	$ 30.00K	$ -8.00K
Other Income Expense	-	$ 77.40K	-	$ -1.09M	$ -827.00K	$ -48.70K
Pretax Income	$ -19.84M	$ -59.24M	$ -47.76M	$ -40.93M	$ -20.77M	$ -24.59M
Tax Provision	$ 2.50K	$ 5.90K	$ 3.40K	$ 2.60K	$ 2.60K	$ 2.60K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -19.84M	$ -59.25M	$ -48.71M	$ -42.32M	$ -22.04M	$ -25.73M
Basic EPS	$ -1.82	$ -8.51	$ -7.50	$ -0.49	$ -0.50	$ -0.90
Diluted EPS	$ -1.82	$ -8.51	$ -7.50	$ 0.00	$ -0.50	$ -0.90
Basic Average Shares	$ 46.81M	$ 6.96M	$ 6.60M	$ 86.13M	$ 43.87M	$ 28.56M
Diluted Average Shares	$ 46.81M	$ 6.96M	$ 6.60M	$ 86.13M	$ 43.87M	$ 28.56M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	$ 354.00K	$ 288.00K
Total Expenses	$ 22.35M	$ 59.04M	$ 48.89M	$ 19.02M	$ 19.97M	$ 24.53M
Net Income From Continuing And Discontinued Operation	$ -19.84M	$ -59.25M	$ -47.76M	$ -40.93M	$ -20.77M	$ -24.59M
Normalized Income	$ -19.64M	$ -47.33M	-	-	$ -20.77M	$ -24.57M
Interest Expense	-	-	-	-	$ 15.00K	$ 8.00K
EBIT	$ -21.66M	$ -59.27M	$ -47.78M	$ -40.93M	$ -20.76M	$ -24.58M
EBITDA	$ -14.60M	$ -58.74M	$ -47.07M	$ -41.05M	$ -20.65M	$ -24.49M

Currency in USD

VistaGen Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing